Literature DB >> 8173501

Naloxone-induced withdrawal in patients with buprenorphine dependence.

A K Nigam1, R P Srivastava, S Saxena, B S Chavan, K R Sundaram.   

Abstract

Naloxone-induced withdrawal was studied in seven patients currently dependent only on injecting buprenorphine, within 3 to 6 hours of their last dose. Withdrawal severity began to rise from 5 minutes and reached a peak at 60 minutes after 1.2 mg naloxone given intravenously. The mean withdrawal severity score was significantly higher at 30, 60 and 90 minutes compared to the baseline. The most frequent withdrawal signs and symptoms were mydriasis, systolic hypertension, tachypnoea, muscle pains, yawning, anxiety, restlessness and craving.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8173501     DOI: 10.1111/j.1360-0443.1994.tb00898.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  7 in total

Review 1.  Buprenorphine-containing treatments: place in the management of opioid addiction.

Authors:  Susan E Robinson
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 2.  Buprenorphine and naloxone for heroin dependence.

Authors:  R E Johnson; J C McCagh
Journal:  Curr Psychiatry Rep       Date:  2000-12       Impact factor: 5.285

3.  The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers.

Authors:  Lisa S Middleton; Paul A Nuzzo; Michelle R Lofwall; David E Moody; Sharon L Walsh
Journal:  Addiction       Date:  2011-05-03       Impact factor: 6.526

4.  Lack of reduction in buprenorphine injection after introduction of co-formulated buprenorphine/naloxone to the Malaysian market.

Authors:  R Douglas Bruce; Sumathi Govindasamy; Laurie Sylla; Adeeba Kamarulzaman; Frederick L Altice
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

5.  Buprenorphine abuse in India : an update.

Authors:  Y Sharma; S K Mattoo
Journal:  Indian J Psychiatry       Date:  1999-04       Impact factor: 1.759

6.  A double blind, within subject comparison of spontaneous opioid withdrawal from buprenorphine versus morphine.

Authors:  D Andrew Tompkins; Michael T Smith; Miriam Z Mintzer; Claudia M Campbell; Eric C Strain
Journal:  J Pharmacol Exp Ther       Date:  2013-11-13       Impact factor: 4.030

7.  A Novel Maintenance Therapeutic for Opioid Use Disorder.

Authors:  Beth Youngblood; Kevin Li; Donald R Gehlert; Julio C Medina; Neil Schwartz
Journal:  J Pharmacol Exp Ther       Date:  2021-05-19       Impact factor: 4.402

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.